Xellia Pharmaceuticals ApS

ACTIVE

Dalslandsgade 11, København S, Hovedstaden, Denmarkwww.xellia.comPrivate1,001–5,000 employeesEstablished: 1903-01-01

Also known as:

Axellia Pharmaceuticals ApS

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1903

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

Approvals

FDA

Food and Drug Administration

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

Approvals

Recent Approvals

XELCOL (1 MIU of Colistimethate Sodium Powder For Solution For injection or infusion)

NPRA

2025-11-28

Polymyxin B Sulfate for Injection

NMPA

2025-04-08

MICAFUNGINA XELLIA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

CIMA_AEMPS

2020-07-27

MICAFUNGINA XELLIA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

CIMA_AEMPS

2020-06-10

DAPTOMICINA XELLIA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

CIMA_AEMPS

2018-12-27

DAPTOMICINA XELLIA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

News

No news articles found

Back to Organizations